TY - JOUR
T1 - LOFIT (Lifestyle front Office For Integrating lifestyle medicine in the Treatment of patients)
T2 - a novel care model towards community-based options for lifestyle change—study protocol
AU - van Dijk, Marlinde L.
AU - te Loo, Leonie M.
AU - Vrijsen, Joyce
AU - van den Akker-Scheek, Inge
AU - Westerveld, Sanne
AU - Annema, Marjan
AU - van Beek, André
AU - van den Berg, Jip
AU - Boerboom, Alexander L.
AU - Bouma, Adrie
AU - de Bruijne, Martine
AU - Crasborn, Jeroen
AU - van Dongen, Johanna M.
AU - Driessen, Anouk
AU - Eijkelenkamp, Karin
AU - Goelema, Nies
AU - Holla, Jasmijn
AU - de Jong, Johan
AU - de Joode, Anoek
AU - Kievit, Arthur
AU - Klooster, Josine van’t
AU - Kruizenga, Hinke
AU - van der Leeden, Marike
AU - Linders, Lilian
AU - Marks-Vieveen, Jenny
AU - Mulder, Douwe Johannes
AU - Muller, Femmy
AU - van Nassau, Femke
AU - Nauta, Joske
AU - Oostvogels, Suzanne
AU - Oude Sogtoen, Jessica
AU - van der Ploeg, Hidde P.
AU - Rijnbeek, Patrick
AU - Schouten, Linda
AU - Schuling, Rhoda
AU - Serné, Erik H.
AU - Smuling, Simone
AU - Soeters, Maarten R.
AU - Verhagen, Evert A. L. M.
AU - Zwerver, Johannes
AU - Dekker, Rienk
AU - van Mechelen, Willem
AU - Jelsma, Judith G. M.
N1 - Funding Information: This study is funded by The Netherlands Organization for Health Research and Development (ZonMw) under grant agreement no. 555003208. The funders will not have any role in data collection, analysis, interpretation of the data or decision to submit results. Publisher Copyright: © 2023, The Author(s).
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Background: A healthy lifestyle is indispensable for the prevention of noncommunicable diseases. However, lifestyle medicine is hampered by time constraints and competing priorities of treating physicians. A dedicated lifestyle front office (LFO) in secondary/tertiary care may provide an important contribution to optimize patient-centred lifestyle care and connect to lifestyle initiatives from the community. The LOFIT study aims to gain insight into the (cost-)effectiveness of the LFO. Methods: Two parallel pragmatic randomized controlled trials will be conducted for (cardio)vascular disorders (i.e. (at risk of) (cardio)vascular disease, diabetes) and musculoskeletal disorders (i.e. osteoarthritis, hip or knee prosthesis). Patients from three outpatient clinics in the Netherlands will be invited to participate in the study. Inclusion criteria are body mass index (BMI) ≥25 (kg/m2) and/or smoking. Participants will be randomly allocated to either the intervention group or a usual care control group. In total, we aim to include 552 patients, 276 in each trial divided over both treatment arms. Patients allocated to the intervention group will participate in a face-to-face motivational interviewing (MI) coaching session with a so-called lifestyle broker. The patient will be supported and guided towards suitable community-based lifestyle initiatives. A network communication platform will be used to communicate between the lifestyle broker, patient, referred community-based lifestyle initiative and/or other relevant stakeholders (e.g. general practitioner). The primary outcome measure is the adapted Fuster-BEWAT, a composite health risk and lifestyle score consisting of resting systolic and diastolic blood pressure, objectively measured physical activity and sitting time, BMI, fruit and vegetable consumption and smoking behaviour. Secondary outcomes include cardiometabolic markers, anthropometrics, health behaviours, psychological factors, patient-reported outcome measures (PROMs), cost-effectiveness measures and a mixed-method process evaluation. Data collection will be conducted at baseline, 3, 6, 9 and 12 months follow-up. Discussion: This study will gain insight into the (cost-)effectiveness of a novel care model in which patients under treatment in secondary or tertiary care are referred to community-based lifestyle initiatives to change their lifestyle. Trial registration: ISRCTN ISRCTN13046877. Registered 21 April 2022.
AB - Background: A healthy lifestyle is indispensable for the prevention of noncommunicable diseases. However, lifestyle medicine is hampered by time constraints and competing priorities of treating physicians. A dedicated lifestyle front office (LFO) in secondary/tertiary care may provide an important contribution to optimize patient-centred lifestyle care and connect to lifestyle initiatives from the community. The LOFIT study aims to gain insight into the (cost-)effectiveness of the LFO. Methods: Two parallel pragmatic randomized controlled trials will be conducted for (cardio)vascular disorders (i.e. (at risk of) (cardio)vascular disease, diabetes) and musculoskeletal disorders (i.e. osteoarthritis, hip or knee prosthesis). Patients from three outpatient clinics in the Netherlands will be invited to participate in the study. Inclusion criteria are body mass index (BMI) ≥25 (kg/m2) and/or smoking. Participants will be randomly allocated to either the intervention group or a usual care control group. In total, we aim to include 552 patients, 276 in each trial divided over both treatment arms. Patients allocated to the intervention group will participate in a face-to-face motivational interviewing (MI) coaching session with a so-called lifestyle broker. The patient will be supported and guided towards suitable community-based lifestyle initiatives. A network communication platform will be used to communicate between the lifestyle broker, patient, referred community-based lifestyle initiative and/or other relevant stakeholders (e.g. general practitioner). The primary outcome measure is the adapted Fuster-BEWAT, a composite health risk and lifestyle score consisting of resting systolic and diastolic blood pressure, objectively measured physical activity and sitting time, BMI, fruit and vegetable consumption and smoking behaviour. Secondary outcomes include cardiometabolic markers, anthropometrics, health behaviours, psychological factors, patient-reported outcome measures (PROMs), cost-effectiveness measures and a mixed-method process evaluation. Data collection will be conducted at baseline, 3, 6, 9 and 12 months follow-up. Discussion: This study will gain insight into the (cost-)effectiveness of a novel care model in which patients under treatment in secondary or tertiary care are referred to community-based lifestyle initiatives to change their lifestyle. Trial registration: ISRCTN ISRCTN13046877. Registered 21 April 2022.
KW - Delivery of Health Care
KW - Delivery of health care
KW - Health behaviour
KW - Lifestyle
KW - Lifestyle front office
KW - Noncommunicable diseases
KW - Randomized controlled trial
KW - lifestyle front office
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85148374410&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36803271
UR - http://www.scopus.com/inward/record.url?scp=85148374410&partnerID=8YFLogxK
U2 - https://doi.org/10.1186/s13063-022-06960-z
DO - https://doi.org/10.1186/s13063-022-06960-z
M3 - Article
C2 - 36803271
SN - 1745-6215
VL - 24
SP - 1
EP - 21
JO - Trials
JF - Trials
IS - 1
M1 - 114
ER -
